People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Venus Concept Inc. | — | Other Health Care | Series C | $194.2M | $9.8M | 2019 |
| Encore Dermatology, Inc. | — | Other Health Care | Series B | $89.6M | $729.9M | 2016 |
| Venus Concept Ltd. | — | Other Health Care | Series B | $66.5M | $311.3M | 2017 |
| Victory Pharma Inc | — | Pharmaceuticals | Series A | $10.0M | $309.7M | 2009 |
Scott Barry at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott Barry on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Garheng Kong | 2 | 16 |
| Juliet Bakker | 2 | 9 |
| William Kelley | 2 | 6 |
| Anthony Natale | 2 | 4 |
| Domenic Serafino | 2 | 3 |
| Louise Lacchin | 2 | 2 |
| Melissa Kang | 2 | 2 |
| Domenic Di Sisto | 2 | 2 |
| Fritz LaPorte | 2 | 2 |
| Anna Georgiadis | 2 | 2 |
| Yoni Iger | 2 | 2 |
| Domenic Della Penna | 2 | 2 |
| Michael Brown | 1 | 34 |
| Craig Taylor | 1 | 13 |
| David Parker | 1 | 11 |
| Frederic Moll | 1 | 10 |
| Adele Oliva | 1 | 9 |
| FRED MOLL | 1 | 8 |
| JEFF BIRD | 1 | 7 |
| Jay K. Hachigian | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.